CXCL10 has been shown to act as a strong inhibitor of angiogenesis [39, 40] and has been implicated in the control of fibrosis in a mouse model of pulmonary fibrosis induced by bleomycin [41]. Here, CXCL10 is linked to pulmonary fibrosis.